NK IMERYS


$ 2.42 $ -0.13 (-5.14 %)    

Friday, 17-Oct-2025 19:56:33 EDT
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 2.4
$ 2.50
$ 2.40 x 100
$ 2.49 x 4,000
$ 2.40 - $ 2.52
$ 1.83 - $ 7.48
9,172,462
na
nm
$ 1.50
nm
TBD
na
na (nm)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 us-stocks-likely-to-open-higher-continuing-record-setting-advances-june-has-never-seen-an-all-time-high-since-1950-highlights-expert

U.S. futures rose on Monday after a record close on Friday. Futures of major benchmark indices were trading higher.

 82-biggest-movers-from-yesterday
82 Biggest Movers From Yesterday
03/10/2021 10:19:51

Gainers INVO Bioscience, Inc. (NASDAQ: INVO) shares surged 202.3% to close at $9.40 on Tuesday after the company announced a...

Core News & Articles

Gainers INVO Bioscience, Inc. (NASDAQ: INVO) shares jumped 230.6% to $10.28 after the company announced an amendment under i...

 38-stocks-moving-in-tuesdays-pre-market-session

Gainers INVO Bioscience, Inc. (NASDAQ: INVO) shares rose 108.4% to $6.48 in pre-market trading after the company announced a...

 immunitybio-and-nantkwest-begin-dosing-participants-in-global-trials-for-covid-19-vaccine

One vaccine, three routes for activating the entire immune system and providing T cell, B cell memory, and mucosal protection...

 61-biggest-movers-from-yesterday
61 Biggest Movers From Yesterday
03/03/2021 08:17:37

Gainers

Core News & Articles

Jim Cramer spoke on CNBC's "Mad Money Lightning Round" about Nantkwest Inc (NASDAQ: NK). He said it is a great immu...

 88-biggest-movers-from-yesterday
88 Biggest Movers From Yesterday
02/24/2021 10:01:42

Gainers Solid Biosciences Inc. (NASDAQ: SLDB) shares surged 41.8% to close at $9.74 on above-average session volume.

 the-daily-biotech-pulse-aridis-to-study-antibody-cocktail-for-coronavirus-variants-revance--protalix-data-readouts

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitti...

Core News & Articles

    During Monday's morning trading, 285 companies set new 52-week highs.

Core News & Articles

    Friday morning saw 331 companies set new 52-week highs.

 the-daily-biotech-pulse-novavax-vaccine-supply-deal-orphan-drug-designation-for-travere-covid-19-boost-for-quidel-opko

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitti...

Core News & Articles

52-Week Highs: Gores Holdings VI (GHVI) Turquoise Hill Resources (TRQ) SOC Telemed (TLMD) Churchill Capital (CCIV) Wix.c...

 the-daily-biotech-pulse-novartis-funding-for-gene-therapy-research-priority-review-for-amgen-cancer-drug-pfizer-biontech-vaccine-supply-deal

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitti...

Core News & Articles

52-Week Highs: HomeStreet (HMST) Applied Genetic (AGTC) BTRS (BTRS) Utz Brands (UTZ) Aviat Networks (AVNW) Golden Enter...

 immunitybio-announces-fda-breakthrough-designation-accelerated-approval-for-cos-superagonist-anktiva-n-803

ImmunityBio Announces ASCO Genitourinary Cancer Symposium Presentation of Phase 2/3 Trial for BCG Unresponsive Non-Muscle Invas...

 immunitybio-announces-asco-genitourinary-cancer-symposium-presentation-of-phase-23-trial-for-bcg-unresponsive-non-muscle-invasive-bladder-cancer-cis-with-71-complete-response-rate

ImmunityBio Announces ASCO Genitourinary Cancer Symposium Presentation of Phase 2/3 Trial for BCG Unresponsive Non-Muscle Invas...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION